Home / Inspections / 1302128

FDA Inspection 1302128 — Ingenus Pharmaceuticals NJ, LLC.

Ingenus Pharmaceuticals NJ, LLC. — FEI 2246963

The FDA completed an inspection of Ingenus Pharmaceuticals NJ, LLC. on January 9, 2026 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fairfield, NJ (United States)

Facility

Other inspections at this facility

  • 1164226 (NAI Fri Feb 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079060 (NAI Thu Jan 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1026727 (VAI Wed Sep 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 994493 (NAI Wed Nov 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 924723 (VAI Mon May 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources